B. Braun Interventional Systems Expands its Congenital and Structural Heart Portfolio With the EmeryGlide™ MR Conditional Guidewire From Nano4Imaging
29 août 2019 15h09 HE
|
B. Braun Medical Inc.--US
BETHLEHEM, Pa., Aug. 29, 2019 (GLOBE NEWSWIRE) -- B. Braun Interventional Systems Inc. (BIS), a company dedicated to providing innovative solutions in the field of congenital and structural...
B. Braun Interventional Systems Receives Breakthrough Device Designation Status from the FDA for SeQuent Please ReX Drug Coated PTCA Balloon Catheter
01 août 2019 09h00 HE
|
B. Braun Medical Inc.--US
BETHLEHEM, Pa., Aug. 01, 2019 (GLOBE NEWSWIRE) -- B. Braun Interventional Systems Inc. (BIS) announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device...